Results 91 to 100 of about 13,254 (218)

Genicular Artery Embolization with Imipenem/Cilastatin for Pigmented Villonodular Synovitis of the Knee: A Case Report

Surgeries
Background: Pigmented villonodular synovitis (PVNS) is a rare, proliferative disorder of the synovium that predominantly affects the knee. Traditional treatment involves surgical resection; however, the high recurrence rates have prompted the exploration
Matteo Cappucci, Riccardo Totti, Guido Bocchino, Rocco Maria Comodo, Giacomo Capece, Pierluigi Maria Rinaldi, Vincenzo De Santis   +6 more
doaj   +1 more source

A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections

Canadian Journal of Infectious Diseases, 1993
Objective: A Canadian multicentre clinical trial in the treatment of intra-abdominal and pelvic infections to compare the efficacy and safety of monotherapy using imipenem-cilastatin (imipenem) (500 mg intravenously every 6 h) versus combination therapy ...
Lionel A Mandell, Pierre L Turgeon, Allan R Ronalds, The Canadian Clinical Trials Group   +3 more
doaj   +1 more source

Alterations in gut microbiota and inflammatory cytokines after administration of antibiotics in mice

Microbiology Spectrum
Antibiotics are widely used to treat bacterial infection and reduce the mortality rate, while antibiotic overuse can cause gut microbiota dysbiosis. The impact of antibiotics on gut microbiota is not fully understood.
Wang Gao, Xingyu Liu, Shuobo Zhang, Jingxia Wang, Bo Qiu, Junhua Shao, Weixin Huang, Yilun Huang, Mingfei Yao, Ling-Ling Tang   +9 more
doaj   +1 more source

A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactam

International Journal of Infectious Diseases, 2019
Objectives: Relebactam is a small molecule β-lactamase inhibitor under clinical investigation for use as a fixed-dose combination with imipenem/cilastatin.
Pratik Bhagunde, Zufei Zhang, Fred Racine, Donna Carr, Jin Wu, Katherine Young, Matthew L. Rizk   +6 more
doaj   +1 more source

Bilateral multifocal pseudomonas aeruginosa keratitis in a contact lens-wearing diabetic patient treated with a custom compounded 5% imipenem-cilastatin topical solution

, 2020
Arzu Taşkıran Çömez, Aydın Yildiz
openalex   +2 more sources

Torsade de Pointes Induced by Hypokalemia from Imipenem and Piperacillin

Case Reports in Cardiology, 2017
Imipenem-cilastatin and piperacillin-tazobactam are two antibiotics with broad antimicrobial coverage. Besides the many well established adverse effects of these drugs, there have been few case reports of hypokalemia.
Varun Kumar, Sandeep Khosla, Monica Stancu   +2 more
doaj   +1 more source

Imipenem - Cilastatin versus Sulbactam - Cefoperazone plus Amikacin in the Initial Treatment of Febrile Neutropenic Cancer Patients [PDF]

, 1999
Özgür Özyılkan, Ulku Yalcintas, Sezgin Baskan   +2 more
openalex   +1 more source

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer) [PDF]

, 1998
Pierre Biron, Christine Fuhrmann, H. Curé, Patrice Viens, D. Lefebvre, Antoine Thyss, M. Viot, P. Soler-Michel, C. Rollin, J. J. Gres   +9 more
openalex   +1 more source

Cost–effectiveness of imipenem/cilastatin/relebactam for hospital-acquired and ventilator-associated bacterial pneumonia

, 2023
Jaesh Naik, Ryan Dillon, Matthew Massello, Lewis Ralph, Zhuo Yang   +4 more
openalex   +1 more source

Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats [PDF]

, 2012
Blanca Humanes, Alberto Lázaro, Sonia Camaño, Estefanía Moreno-Gordaliza, J. A. Lazaro, Montserrat Blanco-Codesido, J M Tunon de Lara, Alberto Ortíz, M. Milagros Gómez-Gómez, Pablo Martı́n-Vasallo, Alberto Tejedor   +10 more
openalex   +1 more source